Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q85122645)
Watch
English
Ovarian cancer: relevant therapy, not timing, is paramount
scientific article published on 01 October 2010
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
title
Ovarian cancer: relevant therapy, not timing, is paramount
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
main subject
ovarian cancer
1 reference
based on heuristic
inferred from title
author
Bradley J. Monk
series ordinal
2
object named as
Bradley J Monk
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
author name string
Robert T Morris
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
language of work or name
English
0 references
publication date
1 October 2010
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
published in
The Lancet
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
volume
376
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
issue
9747
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
page(s)
1120-1122
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
cites work
Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Changing the paradigm in the treatment of platinum-sensitive recurrent ovarian cancer: from platinum doublets to nonplatinum doublets and adding antiangiogenesis compounds
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pegylated liposomal Doxorubicin and Carboplatin compared with Paclitaxel and Carboplatin for patients with platinum-sensitive ovarian cancer in late relapse
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Recurrent epithelial ovarian carcinoma: a randomized phase III study of pegylated liposomal doxorubicin versus topotecan
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine plus carboplatin compared with carboplatin in patients with platinum-sensitive recurrent ovarian cancer: an intergroup trial of the AGO-OVAR, the NCIC CTG, and the EORTC GCG.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961515-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0140-6736(10)61515-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
PubMed publication ID
20888975
1 reference
stated in
Europe PubMed Central
PubMed publication ID
20888975
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20888975%20AND%20SRC:MED&resulttype=core&format=json
retrieved
14 February 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
